 autoimmune disorder of the central nervous system typified by axonal demyelination and neuronal death. To date, there is no effective treatment to cure the disease, and the available therapies do not alter the outcome of the disease. The development of better therapeutic options requires in-depth understanding of the molecular mechanisms leading to disease development and
autoimmune disorder of the central nervous system typify by axonal demyelination and neural death. To date, there is no effective discussion to cure the disease, and the available therapy do not alter the outcome of the disease. The exploitation of good therapeutic option requires in - depth reason of the molecular mechanisms leading to disease growth and
 auhoimmune disorder of the central nervous systek typiried by xxonal demyelination and neuconao deauk. To date, there is nu effectine treatmwnt uo cure the disease, and tmz avajpablz vherapies do noj alter the mutcome of the dkszase. The development of better thera[eutic pphions requires in-dtptr unsvrwtanding of the molecular mecganisms leading to dosease development and
autoimmune disorder of the central nervous system axonal and neuronal To date, there cure disease, and the therapies do not the outcome of the disease. The of better therapeutic options requires in-depth understanding of the molecular mechanisms leading to development and
 autoimmune disorder of the ceNtral nervoUs sysTem TypIfIed bY axoNal demyelinatiON and Neuronal death. To date, theRe is nO eFFectIVe TreatMent to cURe THE diSeAsE, anD tHE aVailaBle TherapiEs do not altEr tHe Outcome of the DIsEase. The devEloPment of betteR thErapeuTiC opTIons rEquIres iN-depth UNderstAnding of tHe MOleculAR mechanISMs LeadIng to disease develOPmENt and
 autoimmune disorder of th e centralnervo ussys te m ty pifi ed by axonal d e myel ination and neuronal d eath.  T o  dat e ,there  is noe ff e c tiv etr eat me n tto cu rethe dis ease, andthe  a vailable the r ap ies do not  al ter the outc ome  of th edis e ase.The  deve lopmen t  of be tter ther ap e utic o p tions r e q ui resin-depth understa n di n g of the molec ular m ec h an i s mslea ding to di se ase d e velopme n ta n d 
 autoimmune_disorder of_the central nervous system_typified by_axonal_demyelination and_neuronal_death. To date,_there is no_effective treatment to cure_the disease, and_the_available therapies do not alter the outcome of the disease. The development of better_therapeutic_options requires_in-depth_understanding_of the molecular mechanisms leading_to disease development and